Hera-MI

Hera-MI brings AI to improve breast cancer early detection to increase recovery rate and to optimize healthcare treatment for women. Breast Cancer is one of the leading cancer causes among women. However, when diagnosed early, patient can recover in almost 90% of cases. Hera-MI is developing a clinical decision support system based on machine learning and medical imaging processing that improve breast cancer early detection. The system enhance diagnosis quality and accuracy while reducing radiologists interpretation time. Moreover Hera-MI solution focuses on patient care improvement. With the more efficient breast cancer screening it allows women to be treated earlier and...

Breast cancer,mammography,tomosynthesis,mri,3d ultrasound,elastography,software,artificial intelligence,image processing,medical imaging,clinical decision support system,senology,ia,mammographie,cad,sénologie,cancer du sein,tomosynthèse,and ai

Hera-mi operates in the Software development industry.

Hera-mi's revenue is 11m - 100m

Hera-mi has 11 - 50 employees.